Anticimex Innovation Center A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.2% 4.2% 4.3% 0.6% 2.7%  
Credit score (0-100)  67 48 46 98 59  
Credit rating  BBB BBB BBB AA BBB  
Credit limit (kDKK)  1.5 0.0 0.0 8,959.5 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  32,558 31,396 41,578 88,001 42,087  
EBITDA  4,857 -2,342 -1,788 54,616 -28.3  
EBIT  4,857 -2,342 -1,788 34,968 -29,678  
Pre-tax profit (PTP)  3,383.0 -1,181.0 -1,566.0 29,190.0 -48,434.4  
Net earnings  3,383.0 -1,181.0 -1,566.0 24,208.2 -37,265.6  
Pre-tax profit without non-rec. items  4,857 -2,342 -1,788 29,190 -48,434  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 18,827 33,659  
Shareholders equity total  37,526 36,345 34,779 58,987 21,722  
Interest-bearing liabilities  0.0 0.0 0.0 162,701 261,851  
Balance sheet total (assets)  76,919 113,830 195,787 315,287 329,689  

Net Debt  0.0 0.0 0.0 162,701 261,851  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  32,558 31,396 41,578 88,001 42,087  
Gross profit growth  -1.6% -3.6% 32.4% 111.7% -52.2%  
Employees  0 0 0 65 74  
Employee growth %  -100.0% 0.0% 0.0% 0.0% 13.8%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  76,919 113,830 195,787 315,287 329,689  
Balance sheet change%  38.3% 48.0% 72.0% 61.0% 4.6%  
Added value  4,857.0 -2,342.0 -1,788.0 34,968.3 -28.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -23,245 0 0 96,775 2,070  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 -1.0 -2.0 1.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  14.9% -7.5% -4.3% 39.7% -70.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  7.3% -2.5% -1.2% 17.0% -8.5%  
ROI %  8.3% -2.5% -1.2% 19.7% -10.1%  
ROE %  9.4% -3.2% -4.4% 51.6% -92.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  100.0% 100.0% 100.0% 18.7% 6.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 297.9% -924,649.3%  
Gearing %  0.0% 0.0% 0.0% 275.8% 1,205.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 17.4% 9.9%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.4 0.2  
Current Ratio  0.0 0.0 0.0 0.8 0.6  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -37,931.0 -116,559.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 538 -0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 840 -0  
EBIT / employee  0 0 0 538 -401  
Net earnings / employee  0 0 0 372 -504